Atrial Strain in Septic Shock (ALARMS)

January 15, 2026 updated by: Centre Hospitalier Universitaire, Amiens

Assessment of Left And Right Atrial Strain in Septic Shock

Septic shock is a critical condition associated with high mortality. Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment. Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases. However, differences exist between echocardiographic software, leading to challenges in result comparability. This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers. The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock. The findings will contribute to improving measurement standardization in critically ill patients.

Study Overview

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)

Description

Inclusion Criteria:

  • Age: >18 years
  • Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)
  • TTE performed as part of medical management
  • No objection to data usage

Exclusion Criteria:

  • Pregnancy
  • Moderate to severe valvular regurgitation/stenosis (>grade 2)
  • Ventricular or supraventricular tachyarrhythmia (HR >140 bpm) at the time of TTE
  • Poor echogenicity preventing LAS measurement
  • Mechanical circulatory support
  • Pacemaker dependence
  • Patients under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
variation of LASr between ECOPAC and UWS
Time Frame: 1 year
Agreement of LAS Reservoir Phase (LASr) measurement in manual mode between ECHOPAC and UWS
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
variation of LAScd between ECHOPAC and UWS
Time Frame: 1 year
Comparison of LAS Conduit (LAScd) measurements in manual mode between ECHOPAC and UWS
1 year
variation of LASct between ECHOPAC and UWS
Time Frame: 1 year
Comparison of LAS Conduit (LAScd) and Contraction (LASct) measurements in manual mode between ECHOPAC and UWS
1 year
Comparison of LASr measurements in apical 2-chamber views
Time Frame: 1 year
Comparison of LASr measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
1 year
Comparison of LAScd measurements in apical 2-chamber views
Time Frame: 1 year
Comparison of LAScd measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
1 year
Comparison of LASct measurements in apical 2-chamber views
Time Frame: 1 year
Comparison of LASct measurements in apical 2-chamber views in manual mode between ECHOPAC and UWS
1 year
Comparison of right atrial strain RASr between ECHOPAC and UWS
Time Frame: 1 year
Comparison of right atrial strain (RASr) in manual mode between ECHOPAC and UWS
1 year
Comparison of right atrial strain RAScd between ECHOPAC and UWS
Time Frame: 1 year
Comparison of right atrial strain RAScd in manual mode between ECHOPAC and UWS
1 year
Comparison of right atrial strain RASct between ECHOPAC and UWS
Time Frame: 1 year
Comparison of right atrial strain RASct in manual mode between ECHOPAC and UWS
1 year
Comparison of LAS in AutoStrain versus manual mode
Time Frame: 1 year
Comparison of LAS measurements in AutoStrain versus manual mode on UWS
1 year
Comparison of RAS in AutoStrain versus manual mode
Time Frame: 1 year
Comparison of RAS measurements in AutoStrain versus manual mode on UWS
1 year
Comparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Time Frame: 1 year
Comparison of LAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
1 year
Comparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
Time Frame: 1 year
Comparison of RAS measurements in AutoStrain (UWS) versus manual mode on ECHOPAC
1 year
Assessment of differences in LAS measurements at end-diastole between ECHOPAC and UWS
Time Frame: 1 year
Assessment of differences in LAS phase measurements between ECHOPAC and UWS
1 year
Assessment of differences in LAS measurements at pre-A between ECHOPAC and UWS
Time Frame: 1 year
Assessment of differences in LAS measurements at pre-A between ECHOPAC and UWS
1 year
Assessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS
Time Frame: 1 year
Assessment of differences in RAS measurements at end-diastole between ECHOPAC and UWS
1 year
Assessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS
Time Frame: 1 year
Assessment of differences in RAS measurements at pre-A between between ECHOPAC and UWS
1 year
Inter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
Inter-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
1 year
Intra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
Intra-observer reproducibility assessment of manual measurements (UWS and GE) in a sample of 10 patients
1 year
Inter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
Inter-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
1 year
Intra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
Time Frame: 1 year
Intra-observer reproducibility assessment of AutoStrain measurements (UWS and GE) in a sample of 10 patients
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

February 11, 2025

First Submitted That Met QC Criteria

February 11, 2025

First Posted (Actual)

February 18, 2025

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 15, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Septic Shock

Subscribe